Morepen Labs zooms 8% on USFDA nod to market anti-allergy drug
NEW DELHI: Shares of Morepen Laboratories soared 8 per cent in early trade on Monday as the drug firm said that it received approval from the US health regulator to market a generic anti-allergy drug in America.
The counter surged to a…